Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Advanced Non-small Cell Lung Cancer
Clinical trial NCT05016544 · UNKNOWN
Trial details
- NCT number
- NCT05016544
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2023-08-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.